Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2023-05-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
112年4月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a revenue summary report for a company named 寶齡富錦, showing monthly and cumulative net operating revenue figures with percentage changes compared to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (775 characters) and it primarily provides a brief financial summary without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement of a report publication. It is a brief financial summary report, which fits best under the category of Fund Information / Factsheet (FS), which is defined as a brief (1-2 page) summary of key company facts and financials.
2023-05-09 Chinese
112年04月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication that this is a full financial report, earnings release, or other types of filings. The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the classification is Director's Dealing (DIRS).
2023-05-09 Chinese
112年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It provides specific data on share counts, pledged shares, and related ratios. The content focuses on insider shareholdings and their changes, which aligns with reporting of personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or regulatory announcements unrelated to insider holdings. The document length is about 3,187 characters, which is sufficient for a detailed insider shareholding report. Therefore, the document fits best under the category of Director's Dealing (DIRS).
2023-05-09 Chinese
112年05月僑外投資持股
Regulatory Filings Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes before and after a shareholders' meeting date. It includes details on share counts and categories but does not contain financial statements, management discussion, or report narrative. The document length is short (1066 characters) and it is a regulatory disclosure related to shareholding statistics rather than a report or announcement of a report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory filing providing shareholding information, which fits best under the 'Regulatory Filings' (RNS) category as a general regulatory announcement that does not fit other specific categories.
2023-05-05 Chinese
公告有關本公司接獲澳豐金融集團(Ayers Alliance Group Limited)通知事宜
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (寶齡富錦生技股份有限公司) regarding a notification received from Ayers Alliance Group Limited about the suspension and revocation of its license by CySEC. It details the impact on the company's investment activities, financial losses recognized, and ongoing communication with the fund issuer. The document is short (1812 characters) and primarily serves as a regulatory announcement about a significant event affecting the company's financial assets and operations. It does not contain comprehensive financial statements or detailed financial performance data. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-21 Chinese
公告有關本公司接獲所投資基金(Spectra SPC Powerfund) 之通知事宜
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a notification received about the liquidation process of an invested fund (Spectra SPC Powerfund). It details the situation with the fund's foreign exchange dealers, complaints filed with regulatory authorities, appointment of liquidators, and the company's financial considerations related to the fund. The document is a disclosure of a material event affecting the company’s financial interests but does not contain financial statements, earnings data, or detailed financial analysis. It is not a full financial report, earnings release, or management discussion. The document is a regulatory announcement informing shareholders and the market about a significant event impacting the company’s investments. Given the content and length (2646 characters), it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-21 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.